LEO Pharma is a Danish global pharmaceutical company specialising in dermatology and thrombosis. Founded in 1908 and headquartered in Ballerup, the group operates in approximately 100 countries. Its Portuguese affiliate, Leo Farmacêuticos Lda, was established in 2002 and is registered at NIF 503932680 with offices in Lisbon.
LEO Pharma entered the Portuguese market in 2002 through its named affiliate Leo Farmacêuticos Lda, registered with Portuguese tax number (NIF) 503932680. The Lisbon-based affiliate sits inside the wider LEO Pharma group structure of approximately 100 country presences, all anchored on the global headquarters in Ballerup, Denmark. The Portuguese organisation acts as the local commercial and medical arm for the group's prescription dermatology portfolio (covering psoriasis, eczema, acne and other chronic skin conditions) and the historical thrombosis and bone-remodelling product lines that LEO Pharma has long supplied across European markets.
LEO Pharma is majority-owned by the LEO Foundation, with Nordic Capital holding a minority stake in the group; both shareholders provide the long-cycle capital that supports a multi-year R&D pipeline focused on chronic skin disease. From a Portuguese-market perspective, that ownership structure gives the local affiliate access to a globally consistent pipeline and reimbursement-grade evidence packages, while regulatory authorisations and pricing decisions in Portugal continue to flow through INFARMED in the standard EU framework.
Among the Danish multinationals operating in Portugal, LEO Pharma is a clean example of a long-running, prescription-grade pharmaceutical presence that pre-dates the more recent wave of Danish capital and infrastructure investment. The 2002 entry, the named Lda subsidiary, and the chronic-disease therapeutic focus make the affiliate a stable, doctor-facing data point in the Nordic-Iberian healthcare corridor — distinct from the high-visibility Danish projects in Portuguese hydrogen, ports and renewables that have driven recent headlines.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →